Compare Alcon AG (ALC) vs Capital One Financial Corp. (COF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Capital One Financial Corp. — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Capital One Financial Corp. trades at $191.98 (market cap $124.98B). The key difference: Capital One Financial Corp. is far larger — about 3.8× Alcon AG's market cap, and Capital One Financial Corp. pays the higher dividend (1.58%). Which is the better fit depends on your goals.
| ALC | COF | |
|---|---|---|
Market Cap | $32.69B | $124.98B |
Sector | Health | Financials |
52-Week High | $92.22 | $257.94 |
52-Week Low | $62.02 | $176.10 |
Enterprise Value | $36.28B | — |
Dividend Yield | 0.54% | 1.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Capital One (COF) trades at $202.89, down 1.09% with a bullish technical outlook despite recent earnings misses. The stock shows strong analyst support with 62.5% buy ratings and a $252 consensus target, representing 24% upside. Recent financials reveal revenue growth to $53.43B in 2025 but declining net margins to 4.59%, while cash flow improved significantly to $18.42B. The company faces regulatory scrutiny and credit risk concerns but benefits from Discover integration and expanding software offerings.
COF presents a compelling risk-reward profile with substantial upside to analyst targets, though investors must weigh strong institutional support against margin pressure and economic sensitivity. The Discover acquisition provides long-term scale advantages, but near-term performance depends on credit quality stability and successful integration execution amid potential recessionary headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →
